Fragment-based Drug Discovery Market, Global Outlook and Forecast 2023-2029

The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.
This report aims to provide a comprehensive presentation of the global market for Fragment-based Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fragment-based Drug Discovery. This report contains market size and forecasts of Fragment-based Drug Discovery in global, including the following market information:
Global Fragment-based Drug Discovery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Fragment-based Drug Discovery market was valued at US$ 342.4 million in 2022 and is projected to reach US$ 522.5 million by 2029, at a CAGR of 6.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Fragment Screening Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Fragment-based Drug Discovery include Astex Pharmaceuticals, Alveus Pharmaceuticals, Beactica, Charles River Laboratories, Crown Bioscience, Emerald BioStructures, Evotec, Kinetic Discovery and Proteros Fragments, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fragment-based Drug Discovery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fragment-based Drug Discovery Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Fragment-based Drug Discovery Market Segment Percentages, by Type, 2022 (%)
    Fragment Screening
    Fragment Optimization
Global Fragment-based Drug Discovery Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Fragment-based Drug Discovery Market Segment Percentages, by Application, 2022 (%)
    Academic and Research Institutions
    Biopharmaceutical Companies
    Contract Research Organizations (CROs)
Global Fragment-based Drug Discovery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Fragment-based Drug Discovery Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fragment-based Drug Discovery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Fragment-based Drug Discovery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Astex Pharmaceuticals
    Alveus Pharmaceuticals
    Beactica
    Charles River Laboratories
    Crown Bioscience
    Emerald BioStructures
    Evotec
    Kinetic Discovery
    Proteros Fragments
    Sprint Bioscience
    Structure Based Design
    Sygnature Discovery
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fragment-based Drug Discovery, market overview.
Chapter 2: Global Fragment-based Drug Discovery market size in revenue.
Chapter 3: Detailed analysis of Fragment-based Drug Discovery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fragment-based Drug Discovery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.